April 27, 2020, TBDWG Meeting (on-line)

April 27, 2020

Meeting Materials

The thirteenth meeting of the Tick-Borne Disease Working Group (TBDWG) was held on April 27, 2020, from 9:00 a.m. to 12:30 p.m., Eastern Time. For this meeting, the TBDWG reviewed the work of the Public Comment and Federal Inventory Subcommittees and the chapters being developed for the 2020 report to Congress on federal tick-borne activities and research.

Federal Register Meeting Notice

Written Public Comment

Meeting Summary

Archived Webcast

If you would like the meeting slide presentation, please send your request to tickbornedisease@hhs.gov.

Time Agenda Item Speaker
9:00 am – 9:03 am Welcome and Roll Call with Introductions Jim Berger, DFO
9:03 am – 9:08 am Recap of Meeting #12
Review of Meeting #13 Agenda, Timeline and Goals
Leigh Ann Soltysiak, Co-Chair
David Walker, Co-Chair
9:08 am – 9:10 am Overview of the Working Group’s Mission, Vision Statement, Values Jim Berger, DFO
9:10 am – 9:40 am Public Comment Leigh Ann Soltysiak, Co-Chair
David Walker, Co-Chair
9:40 am – 9:55 am Public Comment Subcommittee Update Scott Commins, Co-Chair
Angel Davey, Co-Chair
Leigh Ann Soltysiak, Co-Chair
9:55 am – 10:40 am Federal Inventory Subcommittee Update Ben Beard
Dennis Dixon
Sam Donta
Beto Perez de Leon
Pat Smith
David Walker
10:40 am – 10:55 am Chapter 3: Tick Biology, Ecology, and Control Update Kevin Macaluso
Beto Perez de Leon
10:55 am – 11:10 am Chapter 4: Clinical Manifestations, Diagnosis, and Diagnostics Update Sam Donta
Todd Myers
11:10 am – 11:25 am Chapter 5: Causes, Pathogenesis, and Pathophysiology Update Angel Davey
Scott Commins
11:25 am – 11:40 am Chapter 6: Treatment Update Dennis Dixon
Sam Donta
11:40 am – 11:55 am Chapter 7: Clinician and Public Education, Patient Access to Care Update Scott Cooper
Pat Smith
11:55 am – 12:10 pm Chapter 8: Epidemiology and Surveillance Update Ben Beard
Gene Shapiro
12:10 pm - 12:15 pm Review of Meeting #13, Timeline and Next Steps Leigh Ann Soltysiak, Co-Chair
David Walker, Co-Chair
12:15 pm Adjournment Jim Berger, DFO


Content created by Office of Infectious Disease and HIV/AIDS Policy (OIDP)
Content last reviewed